Jinming Song is board-certified in anatomic pathology, surgical pathology, and hematopathology. His specialty is the diagnosis of acute and chronic leukemia, lymphoma, and other benign or malignant hematopoietic disorders. His expertise includes evaluation and interpretation of peripheral blood smears, bone marrow biopsies, lymphoid and non-lymphoid tissues, flow cytometry, molecular pathology, especially NextGen sequencing, and cytogenetics. His research interests are in personalized medicine, the use of gene mutations and cytogenetic abnormalities for the diagnosis, and the prediction of prognosis and treatment responses in patients with hematopoietic disorders. His interests also include the identification of alternative indications for late-stage compounds or drugs.